385 related articles for article (PubMed ID: 33526768)
1. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers.
Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A
Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768
[TBL] [Abstract][Full Text] [Related]
2. FOXM1 promotes hepatocellular carcinoma progression by regulating KIF4A expression.
Hu G; Yan Z; Zhang C; Cheng M; Yan Y; Wang Y; Deng L; Lu Q; Luo S
J Exp Clin Cancer Res; 2019 May; 38(1):188. PubMed ID: 31072351
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1.
Huang X; Qin J; Lu S
Int J Clin Exp Pathol; 2015; 8(2):1515-24. PubMed ID: 25973036
[TBL] [Abstract][Full Text] [Related]
4. Activation of an AKT/FOXM1/STMN1 pathway drives resistance to tyrosine kinase inhibitors in lung cancer.
Li M; Yang J; Zhou W; Ren Y; Wang X; Chen H; Zhang J; Chen J; Sun Y; Cui L; Liu X; Wang L; Wu C
Br J Cancer; 2017 Sep; 117(7):974-983. PubMed ID: 28850563
[TBL] [Abstract][Full Text] [Related]
5. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
6. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer.
Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K
Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813
[TBL] [Abstract][Full Text] [Related]
7. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation.
Wang Y; Wang H; Yan Z; Li G; Hu G; Zhang H; Huang D; Wang Y; Zhang X; Yan Y; Lu Q; Cheng M; Luo S
Cell Commun Signal; 2020 Jul; 18(1):116. PubMed ID: 32723329
[TBL] [Abstract][Full Text] [Related]
8. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
9. High STMN1 level is associated with chemo-resistance and poor prognosis in gastric cancer patients.
Bai T; Yokobori T; Altan B; Ide M; Mochiki E; Yanai M; Kimura A; Kogure N; Yanoma T; Suzuki M; Bao P; Kaira K; Asao T; Katayama A; Handa T; Gombodorj N; Nishiyama M; Oyama T; Ogata K; Kuwano H
Br J Cancer; 2017 Apr; 116(9):1177-1185. PubMed ID: 28334732
[TBL] [Abstract][Full Text] [Related]
10. FOXM1 promotes proliferation in human hepatocellular carcinoma cells by transcriptional activation of CCNB1.
Chai N; Xie HH; Yin JP; Sa KD; Guo Y; Wang M; Liu J; Zhang XF; Zhang X; Yin H; Nie YZ; Wu KC; Yang AG; Zhang R
Biochem Biophys Res Commun; 2018 Jun; 500(4):924-929. PubMed ID: 29705704
[TBL] [Abstract][Full Text] [Related]
11. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway.
Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J
Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057
[TBL] [Abstract][Full Text] [Related]
12. FOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cells.
Hamurcu Z; Ashour A; Kahraman N; Ozpolat B
Oncotarget; 2016 Mar; 7(13):16619-35. PubMed ID: 26918606
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormones suppress FOXM1 expression to reduce liver cancer progression.
Wu CH; Yeh CT; Lin KH
Oncol Rep; 2020 Oct; 44(4):1686-1698. PubMed ID: 32945493
[TBL] [Abstract][Full Text] [Related]
14. LXRα-mediated downregulation of FOXM1 suppresses the proliferation of hepatocellular carcinoma cells.
Hu C; Liu D; Zhang Y; Lou G; Huang G; Chen B; Shen X; Gao M; Gong W; Zhou P; Dai S; Zeng Y; He F
Oncogene; 2014 May; 33(22):2888-97. PubMed ID: 23812424
[TBL] [Abstract][Full Text] [Related]
15. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1.
Liu YP; Pan LL; Kong CC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 is required for small cell lung cancer tumorigenesis and associated with poor clinical prognosis.
Liang SK; Hsu CC; Song HL; Huang YC; Kuo CW; Yao X; Li CC; Yang HC; Hung YL; Chao SY; Wu SC; Tsai FR; Chen JK; Liao WN; Cheng SC; Tsou TC; Wang IC
Oncogene; 2021 Jul; 40(30):4847-4858. PubMed ID: 34155349
[TBL] [Abstract][Full Text] [Related]
17. AKT/FOXM1/STMN1 signaling pathway activation by SMC1A promotes tumor growth in breast cancer.
Li K; Dai P; Li J; Liu L; Cheng S; Fang Q; Wu B
J Gene Med; 2024 Jan; 26(1):e3661. PubMed ID: 38282144
[TBL] [Abstract][Full Text] [Related]
18. Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma.
Tseng YH; Huang YH; Lin TK; Wu SM; Chi HC; Tsai CY; Tsai MM; Lin YH; Chang WC; Chang YT; Chen WJ; Lin KH
Sci Rep; 2016 Dec; 6():38756. PubMed ID: 27934948
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 mediates resistance to docetaxel in gastric cancer via up-regulating Stathmin.
Li X; Yao R; Yue L; Qiu W; Qi W; Liu S; Yao Y; Liang J
J Cell Mol Med; 2014 May; 18(5):811-23. PubMed ID: 24628949
[TBL] [Abstract][Full Text] [Related]
20. XTP8 promotes hepatocellular carcinoma growth by forming a positive feedback loop with FOXM1 oncogene.
Han M; Lu H; Han K; Yuan X; Liu S; Wang Y; Zhao J; Liang P; Cheng J
Biochem Biophys Res Commun; 2019 Jul; 515(3):455-461. PubMed ID: 31164201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
